4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan
I'm PortAI, I can summarize articles.
4D Molecular Therapeutics Inc. granted 13,800 Restricted Stock Units (RSUs) to three new non-executive employees under its 2025 Employment Inducement Award Plan. The RSUs were approved by the board of directors for newly hired team members.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments